Energy News / Shareholders Foundation, Inc.

NASDAQ: ACRS Shareholder Notice: Deadline on September 30, 2019 in Lawsuit Against Aclaris Therapeutics, Inc.

Via: ReleaseWire

Updated 12:00 PM CDT, Mon, September 30,2019

A Deadline is coming up on September 30, 2019 in the lawsuit for certain investors in Aclaris Therapeutics, Inc. (NASDAQ: ACRS).

San Diego, CA -- (SBWIRE) -- 09/30/2019 -- A deadline is coming up on September 30, 2019 in the lawsuit filed for certain investors of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) over alleged securities laws violations by Aclaris Therapeutics, Inc.

Investors who purchased shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Aclaris Therapeutics, Inc. (NASDAQ: ACRSS) common shares between May 8, 2018 and June 20, 2019, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 8, 2018 and June 20, 2019, the Defendants failed to disclose to investors that the Company's advertising materials minimized the risks and overstated the efficacy of ESKATA to generate sales, that, as a result, the Company was reasonably likely to face regulatory scrutiny, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-acrs-shareholder-notice-deadline-on-september-30-2019-in-lawsuit-against-aclaris-therapeutics-inc-1261426.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com